Medical Therapeutics

Tenaya Therapeutics

Brief Description

Tenaya Therapeutics is shaping the future of heart disease treatment driven by a mission to discover, develop, and deliver curative therapies that address the underlying drivers of heart disease. Tenaya is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three platforms: Gene Therapy, Cellular Regeneration, and Precision Medicine. The company was spun out of a new method for creating three-dimensional human heart tissue from stem cells, developed in a collaboration between UC Berkeley Professor of Materials Science...

Evergreen Saponins

Brief Description

Evergreen Saponins is commercializing a sustainable, scalable production method for saponins, unlocking a new supply chain for an essential ingredient in processed food, bio-pesticides, medicines, vaccines, and more. Early in his career, company founder Dr. Ricardo San Martin developed techniques for harvesting saponins from the wood and bark of mature wild trees in Chile, fueling demand for the additive worldwide. Now the chemical engineer has invented a breakthrough method to extract commercial-grade saponins from the leaves of Chilean soapbark trees, Quillaja...

Sift Biosciences

Brief Description

Sift Biosciences supercharges existing cancer therapies by leveraging artificial intelligence and high-throughput cellular screening to discover and design immunotherapy boosters that significantly extend cancer patient survival. The company was co-founded by Yue Clare Lou (BS ’18 Microbial Biology; PhD ’23 Microbiology) and Maddie Williams (PhD student '23-present, Molecular & Cell Biology) to commercize technology developed during their doctoral research at UC Berkeley.

Timeline 2024. Company founded Inventors

Yue "Clare" Lou, Madeline Dee...

CryoVox Technologies

Brief Description

Crovox Technologies is developing new tools for the mass manufacturing of 3D cell cultures.

Timeline 2024. Company founded Inventors

Boris Rubinsky, Michal Adamkievicz, Ze'ev Shaked

KaRNAteq, Inc.

Brief Description

KaRNATeq develops tools for RNA sequencing that are the next step forward in genomics. The enzymes developed by the company enable doctors and scientists to capture more information at reduced cost.

Timeline 2019. Company founded Inventors

Kathleen Collins, Heather Upton

Addition Therapeutics

Brief Description

Addition is transforming genetic medicine by developing RNA-only therapeutics that PRINT™ any genetic element at specific safe harbor sites.

Timeline 2021. Company founded Inventors

Kathy Collins, Jeremy John McIntyre, Sarah Madeline Palm, Heather Upton, Briana Nicole Van Treeck. Xiaozhu Zhang

Juvena Therapeutics

Brief Description

Juvena Therapeutics is a venture-backed biopharma startup discovering novel protein-based therapeutics that promote tissue regeneration in the elderly and treat various age-related diseases. We are building a protein-based discovery platform by implementing an efficient identification, screening and preclinical development pipeline.

Timeline 2017. Company founded Inventors

Michael Conboy, Irina Conboy, David Schaffer, and Hanadie Yousef

Renovis, Inc.

Brief Description

Renovis, Inc. was a biopharmaceutical company developing drugs to treat neurological diseases and disorders. The company used molecular biology, medicinal chemistry, in vitro and in vivo pharmacology, drug metabolism and pharmacokinetics, toxicology, and informatics to identify and select small molecule drug candidates that meet stringent standards for development.

Renovis was founded by UC Berkeley and UCSF faculty. Founder Corey Goodman was the UC Berkeley chair of neurobiology, head of the neurobiology division, and co-founder and director of the Wills...

4D Molecular Therapeutics LLC

Brief Description 4D Molecular Therapeutics is a global leader in gene therapy product research and development using scientific innovation to unlock the full potential of gene therapy for patients with genetic diseases. Their robust discovery platform, termed Directed Vector Evolution, empowers creation of customized gene delivery vehicles (novel AAV vectors) to deliver normal genes to tissues or organs with defective genes. as occurs in genetic diseases. This 4DMT discovery technology was originally developed over 15 years by co-Founder David Schaffer at UC Berkeley. Timeline 2012...

MuscleMatrix

Brief Description

MuscleMatrix is developing a hydrogel that could change how medics treat traumatic injuries on the battlefield, as well as revolutionize surgical repairs for civilians with soft tissue injuries. Traumatic and surgical injuries of soft tissue that involve underlying skeletal muscle remain one of the greatest challenges to tissue reconstruction. Severe injuries, such as those involving the loss of a substantial portion of muscle tissue, are not capable of healing on their own and are referred to as volumetric muscle loss (VML) injuries. By definition, VML results in...